LATEST NEWS
December 09, 2021 | Company Announcements
Bavarian Nordic A/S - Registration of Share Capital Increase of 6,373,680 New Shares CompletedDecember 06, 2021 | Company Announcements
Bavarian Nordic A/S Announces Completion of Directed Issue of 6,373,680 New Ordinary SharesDecember 06, 2021 | Company Announcements
Bavarian Nordic A/S Launches Offering of up to 6,373,680 New Shares in a Directed Issue December 06, 2021 | Company Announcements
Bavarian Nordic Commits to Initiating Phase 3 Trial of RSV Vaccine Candidate and to Strengthening its Capital BaseDecember 05, 2021 | Company Announcements
Bavarian Nordic Reports Positive Topline Phase 2 Results for its COVID-19 Vaccine CandidateNovember 26, 2021 | Company Announcements
Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant ExerciseNovember 12, 2021 | Company Announcements
Bavarian Nordic Announces Interim Results for the First Nine Months of 2021September 24, 2021 | Company Announcements
Bavarian Nordic’s COVID-19 Funding Agreement with the Danish Ministry of Health Receives Final Approval from Parliament September 08, 2021 | Company Announcements
Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant ExerciseSeptember 01, 2021 | Company Announcements
Bavarian Nordic Reports Positive Results from Human Challenge Trial of its RSV Vaccine Candidate